This HTML5 document contains 35 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
n11http://linked.opendata.cz/resource/drugbank/drug/DB08382/identifier/drugbank/
dctermshttp://purl.org/dc/terms/
n9http://linked.opendata.cz/resource/drugbank/drug/DB08382/identifier/chemspider/
n14http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n13http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n7http://linked.opendata.cz/resource/drugbank/drug/DB08382/identifier/pdb/
n4http://linked.opendata.cz/resource/drugbank/property/
n8http://linked.opendata.cz/resource/drugbank/drug/DB08382/identifier/pubchem-compound/
xsdhhttp://www.w3.org/2001/XMLSchema#
n6http://linked.opendata.cz/resource/drugbank/drug/DB08382/identifier/pubchem-substance/

Statements

Subject Item
n2:DB08382
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n13:DB08382 n14:DB08382
dcterms:title
2-(4-{(3S,5S)-5-[(3,3-difluoropyrrolidin-1-yl)carbonyl]pyrrolidin-3-yl}piperazin-1-yl)pyrimidine
adms:identifier
n6:99444853 n7:PF2 n8:11516136 n9:9690926 n11:DB08382
n3:IUPAC-Name
n4:271B52B1-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B52B7-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B52B6-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B52B3-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B52B4-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B52B5-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B52AF-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B52B0-363D-11E5-9242-09173F13E4C5 n4:271B52AD-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B52AE-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B52BD-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B52BE-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B52B8-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B52B9-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B52BB-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B52BA-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B52BC-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B52C2-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B52C4-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B52C5-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B52C1-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B52C0-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B52C3-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B52B2-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B52BF-363D-11E5-9242-09173F13E4C5